4.6 Article

Disruption of Interleukin-1 Signaling Improves the Quality of Wound Healing

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 174, Issue 6, Pages 2129-2136

Publisher

ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2009.080765

Keywords

-

Categories

Funding

  1. National Institutes of Health [GM-042859, GM-066194, GM-079227, P20-RR17695]
  2. Molecular Pathology Core of the COBRE Center for Cancer Research Development
  3. National Center for Research Resources. Institutional Development Award Program
  4. Carter Family Trust
  5. NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM079227, R01GM042859, R01GM066194, R56GM066194] Funding Source: NIH RePORTER

Ask authors/readers for more resources

In this study, we investigated the role of interleukin (IL)-1 signaling in wound heating. IL-1 receptor type I (IL-1R) knockout (KO) mice showed reduced fibrosis in both cutaneous and deep tissue wounds, which was accompanied by a reduction in inflammatory cellular infiltration in cutaneous but not in deep tissue wounds. There were no differences in either total collagenolytic activity or in the expression of selected matrix metalloproteinases; or tissue inhibitors of metalloproteinases between the wound fluids from wildtype or IL-1R KO mice. However, wound fluids from IL-1R KO mice contained lower levels of IL-6 compared with wild-type controls. In addition, the infusion of IL-6 into wounds in IL-1R KO mice did not increase fibrosis. Skin wounds in IL-1R KO animals had lower levels of collagen and improved restoration of normal skin architecture compared with skin wounds in wild-type mice. However, neither the tensile strength of incisional skin wounds nor the rate of closure of excisional wounds differed between IL-1R KO and wild-type animals. The reduced fibrotic response in wounds from IL-1R KO mice could be reproduced by the administration of an IL-1R antagonist. These findings suggest that pharmacological interference with IL-1 signaling could have therapeutic value in the prevention of hypertrophic scarring and in the treatment of fibrotic diseases. (Am J Pathol 2009, 174:2129-2136; DOI:10.2353/ajpath.2009.080765)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available